As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...

Pfizer's CEO Albert Bourla said that he's had dinner with Trump's health secretary pick, RFK Jr.Bourla said he was "cautiously optimistic" about the new administration.Kennedy is now close to securing ...

Dr. Albert Bourla is also troubled by this trend ... first for emergency use in December 2020 and then for full approval in August 2021. It’s also the vaccine that Israel has given to ...

(Bloomberg) -- Pfizer Inc. and Albert Bourla got the upper hand in an early ... the drugmaker have fallen by more than 50% ...

Albert Bourla, CEO of Pfizer since 2019 ... That move alone nearly doubled Pfizer’s revenues in fiscal year 2021 to around $81.3 billion. Since then, the company has fallen behind in the ...

Pfizer’s CEO Ian Read is to step down after eight years and will be replaced on 1st January by chief operating officer Albert Bourla. In contrast to Merck & Co. which has rescinded a company ...

While the exact date of the meeting was not disclosed, Bourla said he and the health secretary nominee chatted civilly, conversing on topics they agreed on rather than straying to more divisive ...

CEO Albert Bourla says Pfizer has met the strategic goals it had set for itself in 2024, and that it was ‘executing transformative changes.’ ...

Pfizer CEO Albert Bourla discusses the major mobilization to deliver a Covid-19 vaccine in record speed, and what it means for medical research, with WSJ's health and science coverage chief ...